{{noteTA
|G1=ME
|1=zh-hans:粥样;zh-tw:粥狀;zh-hant:粥樣
}}
{{medical}}
{{Infobox medical condition
| name          = 动脉粥样硬化<br>Atherosclerosis
| synonyms      = Arteriosclerotic vascular disease (ASVD)
| image         = Endo dysfunction Athero.PNG
| caption       = 动脉粥样硬化的病程  (血管狹窄化的放大圖)
| field         = [[心臟病學|心臟病學]]、[[血管學|血管學]]
| symptoms      = 無{{r|NIH2016Sym}}
| complications = [[冠狀動脈疾病|冠狀動脈疾病]]、[[中風|中風]]、[[周邊動脈阻塞|周邊動脈阻塞]]、[[腎功能衰竭|腎功能衰竭]]<ref name=NIH2016Sym>{{cite web |title=What Are the Signs and Symptoms of Atherosclerosis? |url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/signs |website=NHLBI, NIH |accessdate=2017-11-05 |date=2016-06-22 |archivedate=2017-10-05 |archiveurl=https://web.archive.org/web/20171005113442/https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/signs |deadurl=no |language=en }}</ref>
| onset        = [[青年|青年]] (並且隨著年紀增加而惡化)<ref name=NIH2016Cau>{{cite web|title=What Causes Atherosclerosis? - NHLBI, NIH|url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/causes |website=NHLBI, NIH |accessdate=2017-11-06 |language=en|date=2016-06-22|archivedate=2015-04-23|archiveurl=https://archive.is/20150423115204/http://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/causes|deadurl=no}}</ref> 
| duration =
| causes   = 未知{{r|NIH2016Sym}}
| risks    = [[高血壓|高血壓]]、[[糖尿病|糖尿病]]、[[吸煙|吸煙]]、[[肥胖症|肥胖症]]、家族史、不健康的飲食<ref name=NIH2016Risk>{{cite web|title=Who Is at Risk for Atherosclerosis? - NHLBI, NIH|url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/atrisk |website=NHLBI, NIH |accessdate=2017-11-05 |language=en|date=2016-06-22 |archivedate=2017-10-05|archiveurl=https://web.archive.org/web/20171005113430/https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/atrisk|deadurl=no}}</ref>
| diagnosis    =
| differential =
| prevention   = 健康飲食、規律運動、不抽菸、維持正常體重<ref name=NIH2016Pre>{{cite web |title=How Can Atherosclerosis Be Prevented or Delayed? - NHLBI, NIH |url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/prevention |website=NHLBI, NIH |accessdate=2017-11-06 |language=en |date=2016-06-22 |archive-date=2017-11-07 |archive-url=https://web.archive.org/web/20171107030927/https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/prevention |dead-url=no }}</ref>
| treatment    =
| medication   = [[羟甲基戊二酸单酰辅酶A还原酶抑制剂|Statin]]、[[抗高血压药|抗高血压药]]、[[阿司匹林|阿司匹林]]<ref name=NIH2016Tx>{{cite web |title=How Is Atherosclerosis Treated? |url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/treatment |website=NHLBI, NIH |accessdate=2017-11-06 |language=en |date=2016-06-22 |archive-date=2017-11-07 |archive-url=https://web.archive.org/web/20171107030439/https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/treatment |dead-url=no }}</ref>
| prognosis    =
| frequency    = ~100% (高於65歲)<ref name=AR2013>{{cite book|last1=Aronow|first1=Wilbert S.|last2=Fleg|first2=Jerome L.|last3=Rich|first3=Michael W.|title=Tresch and Aronow's Cardiovascular Disease in the Elderly, Fifth Edition|date=2013|publisher=CRC Press|isbn=9781842145449|page=171|url=https://books.google.nl/books?id=OrbNBQAAQBAJ&pg=PA171|language=en|access-date=2018-05-11|archive-date=2021-08-03|archive-url=https://web.archive.org/web/20210803210024/https://books.google.nl/books?id=OrbNBQAAQBAJ&pg=PA171|dead-url=no}}</ref>
| deaths       = 
}}
{{Infobox disease
| Name = 
| Image = 
| Caption = 
| DiseasesDB = 1039
| ICD10 = {{ICD10|I|70||i|70}}
| ICD9 = {{ICD9|440}}, {{ICD9|414.0}}
| MedlinePlus = 000171
| eMedicineSubj = med
| eMedicineTopic = 182
| MeshID = D050197
}}
{{distinguish|動脈硬化}}
<!-- 定義及症狀 -->
'''动脉粥样硬化'''（{{lang-en|Atherosclerosis}}）是一種{{le|粥樣斑塊|Atheroma}}沉積在血管壁並造成[[動脈|動脈]]狹窄的疾病<ref name=NIH2016Def>{{cite web |title=What Is Atherosclerosis? - NHLBI, NIH |url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis |website=NHLBI, NIH |accessdate=2017-11-06 |language=en |date=2016-06-22 |archive-date=2017-12-02 |archive-url=https://web.archive.org/web/20171202124226/https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/ |dead-url=no }}</ref>。動脈粥樣硬化的早期通常沒有症狀{{r|NIH2016Sym}}，嚴重時視其影響的動脈所在，可能造成[[冠狀動脈疾病|冠狀動脈疾病]]、[[中風|中風]]、[[周邊動脈疾病|周邊動脈疾病]]以及[[腎功能衰竭|腎功能衰竭]]{{r|NIH2016Sym}}。一般而言，動脈粥樣硬化的相關症狀在中年之後才會出現<ref name=NIH2016Risk/>。

<!-- 病因及診斷 -->
目前造成動脈粥樣硬化的原因尚不明朗{{r|NIH2016Sym}}。相關的風險因子包括[[高膽固醇血症|血中膽固醇異常]]、[[高血壓|高血壓]]、[[糖尿病|糖尿病]]、[[吸菸|吸菸]]、[[肥胖症|肥胖]]、動脈粥樣硬化的家族史、以及不健康的飲食習慣<ref name=NIH2016Risk/>。血管壁的斑塊由[[脂肪|脂肪]]、[[膽固醇|膽固醇]]、[[鈣|鈣]]、[[血栓|血栓]]、[[結締組織|結締組織]]、以及其他血中物質組成。斑塊使得血管變得狹窄，含氧血的運送也因此被干擾<ref name=NIH2016Def/>。動脈粥樣硬化的診斷常包括[[理學檢查|理學檢查]]、[[心電圖|心電圖]]、[[心臟壓力測試|心臟壓力測試]]等等 <ref name=NIH2016Diag>{{cite web |title=How Is Atherosclerosis Diagnosed? - NHLBI, NIH |url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/diagnosis |website=NHLBI, NIH |accessdate=2017-11-06 |language=en |date=2016-06-22 |archive-date=2017-10-05 |archive-url=https://web.archive.org/web/20171005113453/https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/diagnosis |dead-url=no }}</ref>。

<!-- 預防及治療 -->
預防動脈粥樣硬化的方式一般包括健康飲食、運動、戒菸、以及維持正常體重<ref name=NIH2016Pre/>、用以降低血中[[膽固醇|膽固醇]]的[[羥甲基戊二酸單醯輔酶A還原酶抑制劑|他汀類藥物]]、[[抗高血压药|抗高血压药]]，或是[[阿斯匹靈|阿斯匹靈]]與[[抗凝血劑|抗凝血劑]]都常用來治療動脈粥狀硬化。除了藥物之外，[[經皮冠狀動脈介入治療|經皮冠狀動脈介入治療]]、[[冠狀動脈旁路移植|冠狀動脈繞道手術]]、以及[[頸動脈內膜切除手術|頸動脈內膜切除手術]]等手術也可以用來治療動脈粥樣硬化<ref name=NIH2016Tx/>。

<!-- 流行病學 -->
動脈粥樣硬化這個疾病最早在1575年就有記載，但疾病本身的歷史遠久於此，在超過5000年前的考古證據中就已經有動脈粥樣硬化的蹤跡<ref name=Al2008>{{cite book|last1=Shor|first1=Allan|name-list-format=vanc|title=Chlamydia Atherosclerosis Lesion: Discovery, Diagnosis and Treatment|date=2008|publisher=Springer Science & Business Media|isbn=9781846288104|pages=8|url=https://books.google.co.uk/books?id=ZEIAhmr7jOMC&pg=PA8|language=en|access-date=2019-02-12|archive-date=2021-08-03|archive-url=https://web.archive.org/web/20210803210031/https://books.google.co.uk/books?id=ZEIAhmr7jOMC&pg=PA8|dead-url=no}}</ref>。動脈粥樣硬化一般在年輕時便已經發生，然後隨著年齡而惡化<ref name=NIH2016Cau/>，大多數的老年人（65歲以上）都患有不同程度的動脈粥樣硬化<ref name=AR2013/>。動脈粥樣硬化是[[已開發國家|已開發國家]]排名第一的致死與致殘疾病<ref>{{cite book|last1=Topol|first1=Eric J.|last2=Califf|first2=Robert M.|name-list-format=vanc|title=Textbook of Cardiovascular Medicine|date=2007|publisher=Lippincott Williams & Wilkins|isbn=9780781770125|pages=2|url=https://books.google.nl/books?id=35zSLWyEWbcC&pg=PA2|language=en|access-date=2019-02-12|archive-date=2021-08-03|archive-url=https://web.archive.org/web/20210803211315/https://books.google.nl/books?id=35zSLWyEWbcC&pg=PA2|dead-url=no}}</ref>。

==病理==
在过去很长时间裡动脉硬化始终是[[医学|医学]]和[[生物化学|生物化学]]研究的重点。其原因是因为它的普及性。许多人有动脉硬化，但是这个状态可以数年、数十年在人体内存在，却不显示出任何病态，然后它会突然以局部缺血、[[心绞痛|心绞痛]]、[[心肌梗塞|心肌梗塞]]、[[中风|中风]]或[[心力衰竭|心力衰竭]]等致命病爆发。在发展国家中动脉硬化后果是最常见的死因。<ref>{{Cite journal|title=The pathogenesis of atherosclerosis: a perspective for the 1990s|author=|url=http://www.nature.com/articles/362801a0|last=Ross|first=Russell|date=1993-04|journal=Nature|issue=6423|doi=10.1038/362801a0|volume=362|pages=801–809|language=en|issn=0028-0836|pmid=8479518|access-date=2022-01-17|archive-date=2021-10-27|archive-url=https://web.archive.org/web/20211027093237/https://www.nature.com/articles/362801a0|dead-url=no}}</ref>

动脉硬化的特征是动脉的慢性退化及动脉壁的逐渐变化。由于结缔组织的增长、细胞内外[[胆固醇|胆固醇]]、[[脂肪酸|脂肪酸]]以及碳酸钙的沉积、[[膠原蛋白|膠原蛋白]]和[[蛋白聚糖|蛋白聚糖]]的聚集动脉壁变硬变厚，动脉变细，整个动脉失去弹性。<ref>{{Cite journal|title=Concept of vulnerable/unstable plaque|url=https://pubmed.ncbi.nlm.nih.gov/20554950|last=Finn|first=Aloke V.|last2=Nakano|first2=Masataka|date=2010-07|journal=Arteriosclerosis, Thrombosis, and Vascular Biology|issue=7|doi=10.1161/ATVBAHA.108.179739|volume=30|pages=1282–1292|issn=1524-4636|pmid=20554950|last3=Narula|first3=Jagat|last4=Kolodgie|first4=Frank D.|last5=Virmani|first5=Renu|access-date=2022-01-17|archive-date=2021-12-07|archive-url=https://web.archive.org/web/20211207143407/https://pubmed.ncbi.nlm.nih.gov/20554950/|dead-url=no}}</ref>

当胆固醇等物质堆积到了足够程度时，[[血管|血管]]的[[内皮细胞|内皮细胞]]会诱导[[单核细胞|单核细胞]]分化为[[巨噬细胞|巨噬细胞]]。巨噬细胞会吞噬血管壁之间的脂肪并使它们堆积于细胞内，[[脂肪|脂肪]]使细胞成为[[泡沫细胞|泡沫细胞]]。<ref>{{cite web|last=Manning|first=Robert|title=Livestrong.com|url=http://www.livestrong.com/article/37332-foam-cell/|work=What Is A Foam Cell?|publisher=Demand Media Inc|accessdate=5 March 2013|archivedate=2017-09-08|archiveurl=https://web.archive.org/web/20170908164837/http://www.livestrong.com/article/37332-foam-cell/|deadurl=no}}</ref>

除[[主动脉|主动脉]]外，常累及心脏的[[冠状动脉|冠状动脉]]和脑、肾动脉，可以引起动脉粥样斑块破裂、[[血栓|血栓]]形成，管腔狭窄至闭塞，从而使有关器官的血液供应发生障碍。

由于动脉硬化过程非常复杂，参加的细胞和组织（[[上皮組織|上皮细胞]]、[[平滑肌|平滑肌]]、[[单核细胞|单核细胞]]、[[巨噬细胞|巨噬细胞]]、[[血小板|血小板]]）、分子（[[脂蛋白|脂蛋白]]、[[生长激素|生长激素]]、胆固醇、脂肪、膠原蛋白和[[细胞因子|细胞因子]]等）多样，其中关系错综，因此至今为止在医学上没有良好的可以预言动脉硬化的模型和技术。

[[File:Arteriosclerosis_&_Atherosclerosis_video.webm|thumb]]

==致病風險因素==

通过众多病史学和临床研究至少可以总结出一定的、有利于动脉硬化形成的因素。
===後天可變的===
*[[糖尿病|糖尿病]]<ref name=nhlbi.nih>{{Cite web |url=https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/atrisk |title=Atherosclerosis |publisher=NHLBI, NIH |accessdate=2018-05-11 |archivedate=2017-10-05 |archiveurl=https://web.archive.org/web/20171005113430/https://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/atrisk |deadurl=no }}</ref>
*[[血脂異常|血脂異常]]{{r|nhlbi.nih}}
*[[吸菸|吸菸]]{{r|nhlbi.nih}}：吸烟可破坏血管壁，诱导平滑肌细胞（SMC）增生；
*[[反式脂肪|反式脂肪]]{{r|nhlbi.nih}}
**高脂血症：公认的危险因素，主要是血浆总[[胆固醇|胆固醇]]和[[甘油三酯|甘油三酯]]的增高，其中尤其胆固醇起关键作用；
*[[肚腩贅肉|腹部肥胖]]{{r|nhlbi.nih}}
*[[西方飲食|西方飲食]]{{r|nhlbi.nih}}
*[[胰岛素抵抗|胰岛素抵抗]]{{r|nhlbi.nih}}
*[[高血壓|高血壓]]{{r|nhlbi.nih}}：高血压病人易发生，并且早而严重，好发于血管分叉、弯曲处；

===後天不可變的===
* [[老化|年紀變大]]{{r|nhlbi.nih}}
* [[雄性|雄性]]{{r|nhlbi.nih}}
* 家族史{{r|nhlbi.nih}}
* [[染色体畸变|染色体畸变]]{{r|nhlbi.nih}}

===機率偏低未被完全確認===
<!-- *[[糖尿病|糖尿病]]、甲状腺功能减退、肾病综合征等使低密度脂蛋白（LDL）升高有关； -->
* 遗传因素：[[冠心病|冠心病]]具有家族聚集现象，约200种基因可能对脂质的摄取、代谢、排泄产生影响。
* 其他：[[肥胖症|肥胖症]]、性别（男性）、高龄、病毒感染、饮食结构（比如高热量和高脂肪的食物；如肉類或油炸食物）被确定为动脉硬化的可能因素。
* [[南亚|南亚]]後裔<ref>{{cite journal |vauthors=Enas EA, Kuruvila A, Khanna P, Pitchumoni CS, Mohan V |title=Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes |journal=Indian J Med Res. |volume=138 |issue=4 |pages=461–491 |date=October 2013 |pmid=24434254 |pmc=3868060 |doi= |url=http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2013;volume=138;issue=4;spage=461;epage=491;aulast=Enas |access-date=2018-05-14 |archive-date=2021-05-18 |archive-url=https://web.archive.org/web/20210518082029/https://www.ijmr.org.in/article.asp?issn=0971-5916;year=2013;volume=138;issue=4;spage=461;epage=491;aulast=Enas |dead-url=no }}</ref><ref name="Indian Heart">Indian Heart Association Why South Asians Facts Web. 30 April 2015. http://indianheartassociation.org/why-indians-why-south-asians/overview/ {{Wayback|url=http://indianheartassociation.org/why-indians-why-south-asians/overview/ |date=20150518111218 }}</ref>
* {{le|血栓形成體質|Thrombophilia}}<ref>{{cite journal |vauthors=Borissoff JI, Spronk HM, Heeneman S, ten Cate H |title=Is thrombin a key player in the 'coagulation-atherogenesis' maze? |journal=Cardiovasc. Res. |volume=82 |issue=3 |pages=392–403 |date=June 2009 |pmid=19228706 |doi=10.1093/cvr/cvp066 |url=http://cardiovascres.oxfordjournals.org/content/82/3/392.long |accessdate=2018-05-14 |archivedate=2011-03-21 |archiveurl=https://web.archive.org/web/20110321003942/http://cardiovascres.oxfordjournals.org/content/82/3/392.long |deadurl=no }}</ref><ref>{{cite journal |vauthors=Borissoff JI, Heeneman S, Kilinç E |title=Early atherosclerosis exhibits an enhanced procoagulant state |journal=Circulation |volume=122 |issue=8 |pages=821–30 |date=August 2010 |pmid=20697022 |doi=10.1161/CIRCULATIONAHA.109.907121 |url=http://circ.ahajournals.org/cgi/content/full/122/8/821 |display-authors=etal |accessdate=2018-05-14 |archivedate=2011-02-12 |archiveurl=https://web.archive.org/web/20110212050126/http://circ.ahajournals.org/cgi/content/full/122/8/821 |deadurl=no }}</ref><ref>{{cite journal |vauthors=Borissoff JI, Spronk HM, ten Cate H |title=The hemostatic system as a modulator of atherosclerosis |journal=N. Engl. J. Med. |volume=364 |issue=18 |pages=1746–60 |date=May 2011 |pmid=21542745 |doi=10.1056/NEJMra1011670 |url=http://www.nejm.org/doi/abs/10.1056/NEJMra1011670 |accessdate=2018-05-14 |archivedate=2020-05-18 |archiveurl=https://web.archive.org/web/20200518061412/https://www.nejm.org/doi/full/10.1056/NEJMra1011670 |deadurl=no }}</ref>
* [[飽和脂肪|飽和脂肪]]{{r|nhlbi.nih}}<ref>{{Cite book | last = Food and nutrition board, institute of medicine of the national academies | title = Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients) | publisher = National Academies Press | year = 2005 | pages = 481–484 | url = http://www.nap.edu/openbook.php?record_id=10490&page=481 | accessdate = 2018-05-14 | archivedate = 2015-09-06 | archiveurl = https://web.archive.org/web/20150906031855/http://www.nap.edu/openbook.php?record_id=10490 | deadurl = no }}</ref>
* 攝取過多[[糖类|糖类]]{{r|nhlbi.nih}}<ref>{{cite journal| pmc=1270002 | pmid=15531663 | volume=80 | title=Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women | url=https://archive.org/details/sim_american-journal-of-clinical-nutrition_2004-11_80_5/page/1175 | date=November 2004 | author=Mozaffarian D, Rimm EB, Herrington DM | journal=Am. J. Clin. Nutr. | pages=1175–84 | doi=10.1093/ajcn/80.5.1175}}</ref>
* 偏高的[[三酸甘油酯|三酸甘油酯]]{{r|nhlbi.nih}}
* {{le|系統性炎症|Systemic inflammation}}<ref name=Bhatt>{{cite journal |vauthors=Bhatt DL, Topol EJ |title=Need to test the arterial inflammation hypothesis |journal=Circulation |volume=106 |issue=1 |pages=136–40 |date=July 2002 |pmid=12093783 |doi=10.1161/01.CIR.0000021112.29409.A2 |url=http://circ.ahajournals.org/cgi/content/full/circulationaha;106/1/136 |author= |accessdate=2018-05-14 |archiveurl=https://web.archive.org/web/20070311014910/http://circ.ahajournals.org/cgi/content/full/circulationaha;106/1/136 |archivedate=2007-03-11 |deadurl=yes }}</ref>
* [[高胰島素血症|高胰島素血症]]<ref name=Hyperinsulinaemia>{{cite journal |vauthors=Griffin M, Frazer A, Johnson A, Collins P, Owens D, Tomkin GH |title=Cellular cholesterol synthesis—the relationship to post-prandial glucose and insulin following weight loss |journal=Atherosclerosis |volume=138 |issue=2 |pages=313–8 |year=1998 |pmid=9690914 | doi = 10.1016/S0021-9150(98)00036-7}}</ref>
* [[睡眠剥夺|睡眠剥夺]]<ref>{{cite journal|pmid=19109114|date=December 2008|author1=King, Cr |author2=Knutson, Kl |author3=Rathouz, Pj |author4=Sidney, S |author5=Liu, K |author6=Lauderdale, Ds |title=Short sleep duration and incident coronary artery calcification|volume=300|issue=24|pages=2859–66|doi=10.1001/jama.2008.867|journal=JAMA: The Journal of the American Medical Association|pmc=2661105}}</ref>
* [[空氣污染|空氣污染]]<ref name="Provost2015">{{cite journal|last1=Provost|first1=EB|last2=Madhloum|first2=N|last3=Int Panis|first3=L|last4=De Boever|first4=P|last5=Nawrot|first5=TS|title=Carotid intima-media thickness, a marker of subclinical atherosclerosis, and particulate air pollution exposure: the meta-analytical evidence|journal=PLoS ONE|date=2015|volume=10|issue=5|pages=e0127014|pmid=25970426|doi=10.1371/journal.pone.0127014|pmc=4430520}}</ref><ref name=PLoSMed42313>{{cite journal |last=Adar |first=Sara D. |author2=Lianne Sheppard |author3=Sverre Vedal |author4=Joseph F. Polak |author5=Paul D. Sampson |author6=Ana V. Diez Roux |author7=Matthew Budoff |author8=David R. Jacobs Jr |author9=R. Graham Barr |author10=Karol Watson |author11=Joel D. Kaufman |title=Fine Particulate Air Pollution and the Progression of Carotid Intima-Medial Thickness: A Prospective Cohort Study from the Multi-Ethnic Study of Atherosclerosis and Air Pollution |journal=PLoS Medicine |date=April 23, 2013 |volume=10 |issue=4 |page=e1001430 |doi=10.1371/journal.pmed.1001430 |url=http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001430 |accessdate=May 4, 2013 |quote=This early analysis from MESA suggests that higher long-term PM2.5 concentrations are associated with increased IMT progression and that greater reductions in PM2.5 are related to slower IMT progression. |pmid=23637576 |pmc=3637008 |archivedate=2014-12-27 |archiveurl=https://web.archive.org/web/20141227234607/http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001430 |deadurl=no }}</ref>
* [[坐式生活型態|久坐的習慣]]{{r|nhlbi.nih}}
* [[砷中毒|砷中毒]]<ref>{{cite web|url=http://circ.ahajournals.org/content/105/15/1804.short|title=Biological Gradient Between Long-Term Arsenic Exposure and Carotid Atherosclerosis|author=Chih-Hao Wang|work=ahajournals.org|accessdate=2018-05-14|archivedate=2017-03-09|archiveurl=https://web.archive.org/web/20170309070543/http://circ.ahajournals.org/content/105/15/1804.short|deadurl=no}}</ref>
* [[酒精_(藥物)|酒精]]{{r|nhlbi.nih}}
* {{le|慢性壓力|Chronic stress}}{{r|nhlbi.nih}}
* [[甲狀腺機能低下症|甲狀腺機能低下症]]<ref>{{cite journal |title=Treating Hypothyroidism Reduces Atherosclerosis Risk|journal=American Family Physician |date=2004-02-01 |url=http://www.aafp.org/afp/2004/0201/p656.html |issn=0002-838X |accessdate=2018-05-14 |archivedate=2019-06-17 |archiveurl=https://web.archive.org/web/20190617090403/https://www.aafp.org/afp/2004/0201/p656.html |deadurl=no |language=en |volume=69 |issue=3 }}</ref>
* [[牙周炎|牙周炎]]<ref>{{cite journal|last1=Bale|first1=BF|last2=Doneen|first2=AL|last3=Vigerust|first3=DJ|title=High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis.|journal=Postgraduate medical journal|date=April 2017|volume=93|issue=1098|pages=215-220|doi=10.1136/postgradmedj-2016-134279|pmid=27899684}}</ref>：感染导致牙龈发炎、损伤，病菌进入血管可导致动脉粥样硬化。<ref>{{cite journal |author1=Jie Yang |author2=Juan Wu |author3=Rui Zhang |author4=Min Yao |author5=Yu Liu |author6=Leiying Miao |author7=Weibin Sun |url=https://www.e-jds.com/article/S1991-7902(16)30096-4/fulltext |title=Porphyromonas gingivalis oral infection promote T helper 17/Treg imbalance in the development of atherosclerosis |date=2016-12-14 |journal=Dental Sciences | pages=60-69 |volume=12 |issue=1 }}</ref>

==預防==
大量流行病學研究和隨機對照臨床試驗證實，[[低密度膽固醇|低密度膽固醇]]的升高是引發動脈粥狀硬化的的一個重要因素<ref>{{Cite journal|title=Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials|url=http://dx.doi.org/10.1016/s0140-6736(10)61350-5|date=2010-11|journal=The Lancet|issue=9753|doi=10.1016/s0140-6736(10)61350-5|volume=376|pages=1670–1681|issn=0140-6736}}</ref>，因此推動終身的健康生活方式與飲食能幫助管理血液中的膽固醇。即使是基因遺傳導致動脈粥狀硬化風險較高的人也可通過改變生活方式來降低多達50%的風險。除此之外，保持正常的體重和血糖、減少單醣和精製碳水化合物攝入量與增加運動頻率均可改善血脂水平並促進健康。<ref>{{Cite journal|title=Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease|url=http://dx.doi.org/10.1016/j.ccl.2015.02.007|last=Brinton|first=Eliot A.|date=2015-05|journal=Cardiology Clinics|issue=2|doi=10.1016/j.ccl.2015.02.007|volume=33|pages=309–323|issn=0733-8651}}</ref>

==治療==
臨床試驗證實可以透過以下藥物減少血液中[[低密度膽固醇|低密度膽固醇]]含量進而減少動脈粥狀硬化心臟病的風險：

* [[他汀類藥物|他汀類藥物]]：[[HMG-CoA_reductase|HMG-CoA reductase]]的競爭性抑制劑，可影響膽固醇合成過程中的速率決定步驟。對HMG-CoA reductase的抑制會使肝臟合成更多LDL受體，使LDL更容易從血液循環內清除。其為降低低密度膽固醇之首選用藥然而需注意其[[肌痛|肌痛]]的不良反應。<ref>{{Cite journal|title=What to Believe and Do About Statin-Associated Adverse Effects|url=http://dx.doi.org/10.1001/jama.2016.16557|last=Thompson|first=Paul D.|date=2016-11-15|journal=JAMA|issue=19|doi=10.1001/jama.2016.16557|volume=316|pages=1969|issn=0098-7484}}</ref>

* [[Ezetimibe|Ezetimibe]]：阻斷[[Niemann-Pick_C1-like_1_cholesterol_transfer_protein|Niemann-Pick C1-like 1 cholesterol transfer protein]]，從而抑制腸道和膽道的膽固醇吸收，使肝臟LDL受體表達增加。通常會與他汀類藥物合用<ref>{{Cite web|title=Faculty of 1000 evaluation for Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.|url=http://dx.doi.org/10.3410/f.725532083.793507596|accessdate=2019-12-31|date=2015-06-21|last=Aronow|first=Wilbert|work=F1000 - Post-publication peer review of the biomedical literature}}</ref>
* [[PCSK9_inhibitor|PCSK9 抑制劑]]：使[[PCSK9_enzyme|PCSK9 enzyme]]失去活性無法分解[[LDL受體|LDL受體]]，從而增加肝細胞上的[[LDL受體|LDL受體]]數量，進而促進血液循環內LDL膽固醇的清除。<ref>{{Cite journal|title=Mutations in PCSK9 cause autosomal dominant hypercholesterolemia|url=http://dx.doi.org/10.1038/ng1161|last=Abifadel|first=Marianne|last2=Varret|first2=Mathilde|date=2003-05-05|journal=Nature Genetics|issue=2|doi=10.1038/ng1161|volume=34|pages=154–156|issn=1061-4036|last3=Rabès|first3=Jean-Pierre|last4=Allard|first4=Delphine|last5=Ouguerram|first5=Khadija|last6=Devillers|first6=Martine|last7=Cruaud|first7=Corinne|last8=Benjannet|first8=Suzanne|last9=Wickham|first9=Louise}}</ref>
* [[N-3_fatty_acid|N-3 fatty acid]]：可減少肝臟內VLDL的生成並少量增加血液循環內VLDL膽固醇的清除，進而通過這一方式降低血中triglyceride濃度。<ref>{{Cite journal|title=Marine n-3 fatty acids and prevention of cardiovascular disease and cancer|url=http://dx.doi.org/10.1530/ey.16.12.13|last=JE|first=Manson|last2=NR|first2=Cook|date=2019-09-12|journal=Yearbook of Paediatric Endocrinology|doi=10.1530/ey.16.12.13|issn=1662-4009|last3=IM|first3=Lee|last4=W|first4=Christen|last5=SS|first5=Bassuk|last6=S|first6=Mora|last7=H|first7=Gibson|last8=CM|first8=Albert|last9=D|first9=Gordon}}</ref>

==參見==
* [[动脉|动脉]]
* [[泡沫细胞|泡沫细胞]]
* [[血管年齡|血管年齡]]
* {{le|動脈粥瘤|atheroma}}

==參考資料==
{{references}}

{{Vascular diseases}}

[[Category:动脉、小动脉与毛细血管疾病|Category:动脉、小动脉与毛细血管疾病]]
[[Category:血管病|Category:血管病]]